- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 5/107 - Tétrapeptides la chaîne latérale du premier amino-acide contenant des carbocycles, p. ex. Phe, Tyr
Détention brevets de la classe C07K 5/107
Brevets de cette classe: 308
Historique des publications depuis 10 ans
|
29
|
30
|
34
|
35
|
35
|
14
|
26
|
19
|
25
|
16
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Stealth Biotherapeutics Inc. | 192 |
21 |
| Eli Lilly and Company | 4106 |
10 |
| Onyx Therapeutics, Inc. | 66 |
9 |
| Vifor Fresenius Medical Care Renal Pharma Ltd. | 56 |
9 |
| The Feinstein Institute for Medical Research | 249 |
8 |
| Cornell Research Foundation, Inc. | 177 |
7 |
| Cytogel Pharma, LLC | 22 |
7 |
| Trustees of Tufts College | 978 |
6 |
| Sichuan Haisco Pharmaceutical Co., Ltd. | 151 |
5 |
| Microsintesis Inc. | 14 |
5 |
| The Regents of the University of California | 20778 |
4 |
| BRANDEIS University | 340 |
4 |
| Cornell University | 3426 |
4 |
| Kyoto University | 2906 |
4 |
| Bristol-myers Squibb Company | 4751 |
3 |
| The Regents of the University of Michigan | 4997 |
3 |
| Arrowhead Pharmaceuticals, Inc. | 350 |
3 |
| King Abdullah University of Science and Technology | 1855 |
3 |
| MannKind Corporation | 546 |
3 |
| Supadelixir Inc. | 25 |
3 |
| Autres propriétaires | 187 |